<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00672568</url>
  </required_header>
  <id_info>
    <org_study_id>114-04P</org_study_id>
    <nct_id>NCT00672568</nct_id>
  </id_info>
  <brief_title>Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder</brief_title>
  <official_title>A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two-Stage Exploratory Study to Evaluate Safety, Tolerability, Efficacy, and Pharmacokinetics of Intraoperative Subacromial Injection With 4975 in Patients Undergoing Arthroscopic Rotator Cuff Repair of the Shoulder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Anesiva, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Anesiva, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety, tolerability and explore the efficacy of
      a single intraoperative injection of 4975 in patients undergoing arthroscopic surgery for
      rotator cuff repair of the shoulder
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, randomized, double-blind, placebo-controlled, two-stage exploratory
      study in patients undergoing arthroscopic rotator cuff repair surgery.

      Stage 1) Patients will be randomized to receive either 4975 or placebo. The dose of 4975 will
      be escalated in a protocolized manner based on safety and tolerability.

      Stage 2) Patients will be randomized in a 1:1 ratio to receive either the selected dose of
      4975 or placebo. All patients will be observed in the hospital for at least two days
      following surgery for safety, tolerability, and efficacy assessments. In addition there will
      be two planned follow-up visits after hospital discharge.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study has been halted after completing Stage 1, for corporate reasons. No future patients will
    be enrolled or treated.
  </why_stopped>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity using a standard 11-point numerical rating system (NRS), which will be assessed at predefined times following surgery</measure>
    <time_frame>28 Days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean overall daily pain and worst daily pain. Pain intensity with physical therapy. Safety outcomes include ECG, vital signs, adverse drug reactions, and wound exams</measure>
    <time_frame>28 Days</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Rotator Cuff Repair of the Shoulder</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4975</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4975</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4975</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4975 - Highly purified capsaicin</intervention_name>
    <description>Solution, 0.5 mg, single dose, injection</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Adlea</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4975 - Highly purified capsaicin</intervention_name>
    <description>Solution, 0.75 mg, single dose, injection</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Adlea</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>4975 - Highly purified capsaicin</intervention_name>
    <description>Solution, 0.1 mg, Single dose, injection</description>
    <arm_group_label>3</arm_group_label>
    <other_name>Adlea</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Solution, single dose, injection</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  Male or female between the ages of 18 and 75 inclusive

          -  In overall good health and planning to undergo unilateral arthroscopic shoulder
             surgery to repair at least one rotator cuff tendon involving humeral attachment

          -  Willing and able to complete the study procedures, pain assessments, and medication
             diaries, and to communicate in Korean or English with study personnel

        Key Exclusion Criteria:

          -  Shoulder surgery requiring concomitant repair of biceps muscle or associated tendon(s)

          -  Planning to undergo shoulder surgery on both shoulders

          -  Use of disallowed pain medications prior to the surgery

          -  Female patients who are pregnant or lactating or who plan to get pregnant

          -  Diabetes mellitus with a known HbA1C&gt;9.5
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shaun Comfort, MD</last_name>
    <role>Study Director</role>
    <affiliation>Anesiva, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kyungpook National university Hospital</name>
      <address>
        <city>Daegu</city>
        <state>Jung-gu</state>
        <zip>700-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Kyunggido</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gyeongsang National University Hospital</name>
      <address>
        <city>Jinju</city>
        <state>Kyungsangnamdo</state>
        <zip>660-720</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kangnam St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Seocho-gu</state>
        <zip>137-040</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://www.anesiva.com/wt/page/pipeline</url>
    <description>Anesiva Home Page</description>
  </link>
  <link>
    <url>http://www.anesiva.com/wt/page/adlea</url>
    <description>ADLEA Product Information</description>
  </link>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2008</study_first_submitted>
  <study_first_submitted_qc>May 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2008</study_first_posted>
  <last_update_submitted>May 1, 2009</last_update_submitted>
  <last_update_submitted_qc>May 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>Shaun Comfort, MD</name_title>
    <organization>Anesiva, Inc.</organization>
  </responsible_party>
  <keyword>Rotator cuff, Shoulder, Arthroscopic shoulder surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Capsaicin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

